ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,166.25
0.75%
US Tech 100
17,546.00
0.73%
다우존스 지수
38,828.01
0.39%
Bitcoin
63,180.98
-1.28%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Nurix Therapeutics Inc (NRIX)

  7. Nurix Therapeutics Inc (NRIX) 뉴스

NRIX Nurix Therapeutics Inc

13.27
0.49 (3.83%)
최종 업데이트: 03:00:10
15분 지연
기업명 주식 심볼 시장 주식 타입
Nurix Therapeutics Inc NRIX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.49 3.83% 13.27 03:00:10
개장가 저가 고가 종가 전일 종가
12.81 12.77 13.51 12.78
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202407:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
12/04/202412:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
12/04/202405:00GLOBENurix Therapeutics Announces Proposed Public Offering
10/04/202420:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
10/04/202402:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
09/04/202420:00GLOBENurix Therapeutics Announces Extension of Strategic..
03/04/202420:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
02/04/202420:00GLOBENurix Therapeutics Announces Extension of Strategic..
25/03/202420:00GLOBENurix Therapeutics is Part of a Team of International..
20/03/202422:40GLOBENurix Presents the Discovery and Chemical Structure of..
11/03/202420:02EDGAR2Form 8-K - Current report
11/03/202420:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
07/03/202406:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
06/03/202406:30GLOBENurix Therapeutics Announces Presentations at the American..
17/02/202409:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:22EDGAR2Form 144 - Report of proposed sale of securities
16/02/202406:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/02/202406:01EDGAR2Form 8-K - Current report
16/02/202406:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
15/02/202421:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202421:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202421:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202406:01GLOBENurix Therapeutics Announces Publication in the Journal..
31/01/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202408:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/01/202406:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
17/01/202406:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
08/01/202421:03EDGAR2Form 8-K - Current report
08/01/202421:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
03/01/202406:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..
22/12/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:19EDGAR2Form 144 - Report of proposed sale of securities
14/12/202306:32GLOBEJudith A. Reinsdorf and Katherine M. Sandstrom Named to Toll..
12/12/202302:03EDGAR2Form 8-K - Current report
12/12/202302:00GLOBENurix Therapeutics Presents Positive Clinical Data from Its..
05/12/202306:01GLOBENurix Therapeutics Announces Webcast To Review Data from Its..
13/11/202321:01EDGAR2Form 8-K - Current report
08/11/202306:01GLOBENurix Therapeutics to Participate in Upcoming Investor..
02/11/202322:00GLOBENurix Therapeutics Announces Presentations at the 65th..
02/11/202306:16DJNNurix Therapeutics Says FDA Places Partial Clinical Hold on..
02/11/202305:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:02EDGAR2Form 8-K - Current report
02/11/202305:01GLOBENurix Therapeutics Announces Partial Clinical Hold For..
13/10/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

NASDAQ
NRIX
Nurix Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유